@article{Bezborodova_2020,<br/><span class="tab"></span> title={Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies},<br/><span class="tab"></span> volume={10},<br/><span class="tab"></span> ISSN={1991-2919},<br/><span class="tab"></span> url={http://dx.doi.org/10.30895/1991-2919-2020-10-2-96-110},<br/><span class="tab"></span> DOI={10.30895/1991-2919-2020-10-2-96-110},<br/><span class="tab"></span> number={2},<br/><span class="tab"></span> journal={The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products},<br/><span class="tab"></span> publisher={SCEEMP},<br/><span class="tab"></span> author={Bezborodova,<br/><span class="tab"></span> O,<br/><span class="tab"></span> A. and Pankratov,<br/><span class="tab"></span> A. A. and Nemtsova,<br/><span class="tab"></span> E. R. and Venediktova,<br/><span class="tab"></span> Yu. B. and Vorontsova,<br/><span class="tab"></span> M. S. and Engalycheva,<br/><span class="tab"></span> G. N. and Syubaev,<br/><span class="tab"></span> R. D.},<br/><span class="tab"></span> year={2020},<br/><span class="tab"></span> month=jun,<br/><span class="tab"></span> pages={96–110} }